Imperva Inc (NYSE:IMPV) received a $56.00 price objective from investment analysts at Evercore ISI in a research report issued on Thursday. The brokerage currently has a “buy” rating on the software maker’s stock. Evercore ISI’s target price points to a potential upside of 25.14% from the company’s previous close.

Other research analysts have also issued reports about the company. Stifel Nicolaus reaffirmed a “hold” rating and issued a $47.00 price objective on shares of Imperva in a report on Friday, July 14th. Stephens reaffirmed an “overweight” rating and issued a $61.00 price objective (up from $53.00) on shares of Imperva in a report on Thursday, July 13th. BidaskClub lowered Imperva from a “buy” rating to a “hold” rating in a report on Tuesday, July 25th. ValuEngine lowered Imperva from a “hold” rating to a “sell” rating in a report on Tuesday, July 11th. Finally, Monness Crespi & Hardt upped their price objective on Imperva from $55.00 to $57.00 and gave the company a “buy” rating in a report on Friday, July 28th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have assigned a buy rating to the company’s stock. Imperva has an average rating of “Hold” and an average price target of $50.97.

Shares of Imperva (NYSE:IMPV) traded up 6.93% during trading on Thursday, reaching $44.75. 855,817 shares of the company traded hands. The stock’s 50 day moving average price is $43.78 and its 200-day moving average price is $45.86. The stock’s market cap is $1.51 billion. Imperva has a 12 month low of $34.40 and a 12 month high of $52.40.

Imperva (NYSE:IMPV) last posted its earnings results on Thursday, July 27th. The software maker reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.15). The business had revenue of $74.44 million for the quarter, compared to analyst estimates of $74.30 million. Imperva had a negative return on equity of 5.00% and a negative net margin of 4.69%. The firm’s revenue was up 28.6% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.23) earnings per share. On average, equities research analysts expect that Imperva will post $0.81 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Imperva Inc (IMPV) Given a $56.00 Price Target by Evercore ISI Analysts” was first reported by American Banking News and is owned by of American Banking News. If you are reading this story on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this story can be read at https://www.americanbankingnews.com/2017/10/21/imperva-inc-impv-given-a-56-00-price-target-by-evercore-isi-analysts.html.

In related news, Director Anthony J. Bettencourt sold 99,598 shares of the company’s stock in a transaction on Thursday, August 24th. The stock was sold at an average price of $43.59, for a total transaction of $4,341,476.82. Following the completion of the sale, the director now directly owns 99,598 shares in the company, valued at approximately $4,341,476.82. The sale was disclosed in a filing with the SEC, which is available through this link. 2.20% of the stock is owned by corporate insiders.

Several hedge funds have recently made changes to their positions in IMPV. Ameritas Investment Partners Inc. bought a new stake in shares of Imperva during the 1st quarter worth $102,000. KCG Holdings Inc. bought a new stake in shares of Imperva during the 1st quarter worth $201,000. Migdal Insurance & Financial Holdings Ltd. lifted its position in shares of Imperva by 26.2% during the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 4,177 shares of the software maker’s stock worth $201,000 after buying an additional 866 shares during the last quarter. Amalgamated Bank bought a new stake in shares of Imperva during the 2nd quarter worth $206,000. Finally, Principal Financial Group Inc. bought a new stake in shares of Imperva during the 2nd quarter worth $223,000. Institutional investors and hedge funds own 92.72% of the company’s stock.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NYSE:IMPV)

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.